Publications by authors named "Liz Masson"
Am J Cardiol
December 2019
Article Synopsis
- Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder causing extremely high LDL cholesterol levels and early cardiovascular disease, with limited response to current treatments.
- Gemcabene is a new lipid-lowering medication that works independently of the LDL receptor, showing promise in helping lower LDL cholesterol when added to existing treatments.
- In the COBALT-1 study involving eight HoFH patients, gemcabene significantly reduced LDL cholesterol levels over 12 weeks, suggesting it could be an effective adjunct therapy for managing this condition.
